We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
XLS.SW

Price
21.00
Stock movement down
-1.80 (-7.89%)
Company name
Xlife Sciences AG
Exchange
(SW
,
Currency
CHF
)
Sector
Healthcare >
Biotechnology
Market cap
120.57M
Ent value
267.31M
Price/Sales
87.63
Price/Book
0.33
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
14.31
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-51.50%
3 year return
-21.07%
5 year return
-
10 year return
-
Last updated: 2025-04-05

DIVIDENDS

XLS.SW does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E14.31
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales87.63
Price to Book0.33
EV to Sales194.27

FINANCIALS

Per share

Per share data
Current share count5.74M
EPS (TTM)1.51
FCF per share (TTM)-1.95

Income statement

Income statement data
Revenue (TTM)1.38M
Gross profit (TTM)309.00K
Operating income (TTM)-31.95M
Net income (TTM)8.43M
EPS (TTM)1.51
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)22.46%
Operating margin (TTM)-2321.71%
Profit margin (TTM)612.53%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash218.71K
Net receivables9.13M
Total current assets18.12M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment771.10K
Total assets511.99M
Accounts payable971.90K
Short/Current long term debt0.00
Total current liabilities5.83M
Total liabilities146.96M
Shareholder's equity365.04M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-10.75M
Capital expenditures (TTM)160.03K
Free cash flow (TTM)-10.91M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity2.31%
Return on Assets1.65%
Return on Invested Capital2.00%
Cash Return on Invested Capital-2.59%

STOCK INFORMATION

Stock chart

Stock price data
Open22.30
Daily high22.70
Daily low20.20
Daily Volume3K
All-time high52.00
1y analyst estimate68.00
Beta0.55
EPS (TTM)1.51
Dividend per share-
Ex-div date-
Next earnings date25 Apr 2025

Downside potential

Downside potential data
XLS.SWS&P500
Current price drop from All-time high-59.62%-17.56%
Highest price drop-65.96%-56.47%
Date of highest drop4 Mar 20259 Mar 2009
Avg drop from high-34.03%-11.07%
Avg time to new high262 days12 days
Max time to new high783 days1805 days
COMPANY DETAILS
XLS.SW (Xlife Sciences AG) company logo
Marketcap
120.57M
Marketcap category
Small-cap
Description
Xlife Sciences AG focuses on the development and commercialization of technologies in the life sciences sector. The company's project consists of technology platforms that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also engages in developing mono-and bispecific anti-tumor antibodies for the treatment of life-threatening diseases; researching, developing, and manufacturing chemical and active pharmaceutical ingredients for human and veterinary medicines; and early identification kidney diseases. Xlife Sciences AG also focuses on functional screening of antibodies by microfluidics-based technologies; and offers Neuromex, a screening instrument for the early-stage detection of neurodegenerative diseases. Xlife Sciences AG was founded in 2019 and is based in Zurich, Switzerland.
Employees
17
Website
https://www.xlifesciences.ch
Investor relations
-
SEC filings
XLS.SW SEC filings
CEO
Country
Switzerland
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved